Health Care & Life Sciences » Pharmaceuticals | Zhenxing Biopharmaceutical & Chemical Co. Ltd.

Zhenxing Biopharmaceutical & Chemical Co. Ltd. | Mutual Funds

Mutual Funds that own Zhenxing Biopharmaceutical & Chemical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
3,885,326
1.47%
-6,909,472
3.6%
12/31/2017
855,381
0.32%
-2,144,641
0.64%
12/31/2017
742,944
0.28%
-3,035,888
1.49%
12/31/2017
642,253
0.24%
-976,747
1.36%
12/31/2017
China AMC Income Fund
464,274
0.18%
-785,605
0.52%
12/31/2017
456,920
0.17%
-825,220
0.88%
12/31/2017
390,500
0.15%
-414,000
0.75%
12/31/2017
China AMC Industry Select Fund
219,903
0.08%
-580,007
0.28%
12/31/2017
146,665
0.06%
86,740
2.42%
12/31/2017
96,363
0.04%
-1,668,073
1.06%
12/31/2017

About Zhenxing Biopharmaceutical & Chemical Co.

View Profile
Address
16/F, Gaoxin International Building
Taiyuan Shanxi 030006
China
Employees -
Website -
Updated 07/08/2019
Zhenxing Biopharmaceutical & Chemical Co., Ltd. engages in the production and marketing of pharmaceutical products. It specializes in human serum albumin, intravenous human immunoglobulin, human immunoglobulin, human hepatitis B immunoglobulin, tetanus human immunoglobulin, and rabies immunoglobulin. The company was founded on May 22, 1995 and is headquartered in Taiyuan, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.